• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program

    10/28/24 11:05:00 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care
    Get the next $DVA alert in real time by email

    The program aims to bring together a supportive network for people dealing with chronic health challenges for themselves and their loved ones

    DENVER, Oct. 28, 2024 /PRNewswire/ -- The DaVita Giving Foundation today announced an investment in the National Kidney Foundation (NKF)'s PEERS program, a program that provides social and emotional support for patients, care partners, and living donors through connections with mentors living through similar experiences.

    Prioritizing mental health in chronic disease care is essential, and mentorship can help provide people with support and comfort in a time when they might otherwise feel alone. Studies1 show that social connection can help reduce the risk of chronic disease and other serious illness, and lead to better mental and physical health.

    "Receiving a chronic disease diagnosis can be a distressing and emotional experience for patients as well as their loved ones. Patients with chronic kidney disease (CKD) often manage multiple health conditions at once, and our dedicated care teams come together to support patients throughout their kidney care journey. While the support of care teams and partners is invaluable, nothing quite matches the comfort and understanding that comes from connecting with peers," remarked Dr. Jeff Giullian, chief medical officer for DaVita, a leading provider of kidney care services. "We celebrate the NKF PEERS program for its commitment to connecting patients with a broader health community, and we are truly grateful to be part of this vital effort."

    Today, more than 356 individuals participate as mentors and mentees in the program, with 81% of participants managing a chronic illness like kidney failure.

    "Going through a kidney disease diagnosis, being on dialysis, and getting evaluated for a transplant can be such a lonely process. NKF PEERS helps people in these moments make connections with someone else who's 'been there before,'" said Marissa Argentina, patient programs director for the NKF. "Connecting with trained peer mentors who have those lived experiences, can share their stories and are able to be a source of support for someone new to living with kidney disease, dialysis or transplant can make a huge difference."

    Patients living with chronic disease are significantly more likely to experience depression and other mental health conditions2, and studies3 show that social connection improves the psychological well-being of those living with mental health conditions.

    "When I first started dialysis, I felt depressed, so I asked my social worker at DaVita if there was a program where I could talk to someone experiencing the same things I was," said Felicia Tarnecki, DaVita patient and mentee participant in NKF PEERS. "My mentor answered my questions, and we talked on the phone often. It helped me feel less alone and more in control of my health."

    The program connects participants telephonically and provides them with an opportunity to discuss their kidney care journey and ask questions in a comfortable environment with someone who has lived through similar experiences.

    "I want to give others the encouragement through their journey that I wish I'd had, because I felt like nobody understood what I was going through," said Janine Prazza, mentor for the NKF PEERS program and a dual heart and kidney transplant recipient.

    To learn more about DaVita's giving and community partnerships, visit DaVita.com/About. To learn more about support groups and other resources for those affected by kidney disease, visit DaVita.com/Support or Kidney.org/PEERS.

    About DaVita Inc.

    DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

    Media Contact:

    DaVita Newsroom

    [email protected]

    1Centers for Disease Control and Prevention (2024, March 27). Social Connection. U.S. Centers for Disease Control and Prevention. Retrieved October 2, 2024, from https://www.cdc.gov/social-connectedness/about/index.html

    2Based on 2021 data. John's Hopkins (2021, December 16). The Intersection of Mental Health and Chronic Disease. Johns Hopkins Bloomberg School of Public Health. https://publichealth.jhu.edu/2021/the-intersection-of-mental-health-and-chronic-disease

    3Based on 2017 data. Harandi TF, Taghinasab MM, Nayeri TD. The correlation of social support with mental health: A meta-analysis. Electron Physician. 2017 Sep 25;9(9):5212-5222. doi: 10.19082/5212. PMID: 29038699; PMCID: PMC5633215.

    DaVita Logo (PRNewsfoto/DaVita)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-emphasizes-commitment-to-whole-person-care-with-investment-in-national-kidney-foundation-peers-program-302288210.html

    SOURCE DaVita

    Get the next $DVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is the PEERS program and what does it offer?

      The PEERS program provides social and emotional support for patients, care partners, and living donors by connecting them with mentors who have similar experiences with chronic illnesses, especially kidney disease.

    • How many individuals are involved in the PEERS program and what percentage manage a chronic illness?

      More than 356 individuals are currently participating in the PEERS program as mentors and mentees, with 81% of these participants managing chronic illnesses such as kidney failure.

    • How does the PEERS program facilitate connections between participants?

      The program connects participants telephonically, allowing them to discuss their kidney care journey in a comfortable environment with someone who has lived through similar experiences, providing valuable support.

    • What do studies indicate about the impact of social connections on health?

      Studies show that social connection can help reduce the risk of chronic disease and other serious illnesses, leading to improved mental and physical health, particularly for individuals with chronic diseases.

    • What did Dr. Jeff Giullian say about the importance of peer connections for patients?

      Dr. Jeff Giullian emphasized that while dedicated care teams provide essential support, nothing compares to the comfort and understanding that comes from connecting with peers who share similar health struggles.

    Recent Analyst Ratings for
    $DVA

    DatePrice TargetRatingAnalyst
    3/6/2024$133.00Equal Weight
    Barclays
    8/7/2023$100.00 → $142.00Neutral → Buy
    UBS
    11/1/2022$97.00 → $72.00Buy → Hold
    Deutsche Bank
    10/31/2022$117.00 → $74.00Buy → Neutral
    UBS
    8/19/2022$106.00 → $117.00Buy
    UBS
    6/21/2022$110.00 → $90.00Underperform
    BofA Securities
    1/5/2022$114.00 → $125.00Hold
    Truist Securities
    10/29/2021$113.00 → $111.00Sector Perform
    RBC Capital
    More analyst ratings

    $DVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal & Pub. Affairs Off Waters Kathleen Alyce exercised 8,079 shares at a strike of $108.93, returned $880,100 worth of shares to the company (5,898 units at $149.22) and covered exercise/tax liability with 817 shares, increasing direct ownership by 1% to 99,118 units (SEC Form 4)

    4 - DAVITA INC. (0000927066) (Issuer)

    2/9/26 6:57:03 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    CFO and Treasuer Ackerman Joel covered exercise/tax liability with 5,100 shares, exercised 44,065 shares at a strike of $108.93 and returned $4,800,109 worth of shares to the company (32,168 units at $149.22), increasing direct ownership by 5% to 148,437 units (SEC Form 4)

    4 - DAVITA INC. (0000927066) (Issuer)

    2/9/26 6:56:25 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Chief Compliance Officer Hearty James O exercised 5,875 shares at a strike of $108.93, returned $639,969 worth of shares to the company (5,412 units at $118.25) and covered exercise/tax liability with 203 shares, increasing direct ownership by 1.00% to 26,298 units (SEC Form 4)

    4 - DAVITA INC. (0000927066) (Issuer)

    12/5/25 4:35:57 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $DVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

    DENVER, Feb. 24, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026 at 11:50 am EST.To view the live webcast, visit the TD Cowen page here and create a free registration.About DaVita Inc.DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 25 years. DaVita c

    2/24/26 2:00:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Inc. 4th Quarter 2025 Results

    DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment," said Javier Rodriguez, CEO of DaVita. "Given our ongoing investments and process improvements, we are confident in our ability to continue to deliver both clinically and financially in 2026 and beyond." Financial and operating highlights for the quarter and year ended December 31, 2025: Consolidated revenues were $3.620 billion

    2/2/26 4:05:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Elara Caring Secures New Strategic Investment from Ares and DaVita

    Partnership will accelerate Elara's growth and evolution as home health care leader; expand access to high-acuity care for complex diseases through new offerings Elara Caring (Elara), a leading national provider of skilled home health, hospice, behavioral health, and personal care services, today announced that it has entered into an agreement for a strategic investment from Ares' Private Equity Group (Ares) and DaVita. The investment is intended to expand access to personalized, clinically advanced care at home for patients with complex and acute needs. Elara will continue to operate as a wholly independent company led by CEO Ananth Mohan and the current management team. Following the cl

    2/2/26 3:00:00 PM ET
    $ARES
    $DVA
    Investment Managers
    Finance
    Misc Health and Biotechnology Services
    Health Care

    $DVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on DaVita with a new price target

    Barclays initiated coverage of DaVita with a rating of Equal Weight and set a new price target of $133.00

    3/6/24 8:09:27 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita upgraded by UBS with a new price target

    UBS upgraded DaVita from Neutral to Buy and set a new price target of $142.00 from $100.00 previously

    8/7/23 7:20:56 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded DaVita from Buy to Hold and set a new price target of $72.00 from $97.00 previously

    11/1/22 9:18:39 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $DVA
    SEC Filings

    View All

    SEC Form 10-K filed by DaVita Inc.

    10-K - DAVITA INC. (0000927066) (Filer)

    2/11/26 4:06:39 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DAVITA INC. (0000927066) (Filer)

    2/2/26 4:07:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - DAVITA INC. (0000927066) (Filer)

    11/25/25 5:01:10 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $DVA
    Financials

    Live finance-specific insights

    View All

    DaVita Inc. 4th Quarter 2025 Results

    DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment," said Javier Rodriguez, CEO of DaVita. "Given our ongoing investments and process improvements, we are confident in our ability to continue to deliver both clinically and financially in 2026 and beyond." Financial and operating highlights for the quarter and year ended December 31, 2025: Consolidated revenues were $3.620 billion

    2/2/26 4:05:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

    DENVER, Jan. 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 2, 2026 at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:  Monday, February 2, 2026Starting at 5:00 p.m. ESTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042 When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen

    1/21/26 10:00:00 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Inc. 3rd Quarter 2025 Results

    DENVER, Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended September 30, 2025. "Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance," said Javier Rodriguez, CEO of DaVita. "Our consistent focus on providing outstanding care is the key to these results, enabling us to continuously invest in improving the lives of our patients and supporting our dedicated teammates and physician partners." Financial and operating highlights for the quarter ended September 30, 2025: Consolidated revenues were $3.420 billion.Operating income was $506 million and adjusted operating

    10/29/25 4:05:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $DVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

    SC 13G/A - DAVITA INC. (0000927066) (Subject)

    2/13/24 5:02:42 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

    SC 13G/A - DAVITA INC. (0000927066) (Subject)

    2/9/22 3:43:35 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by DaVita Inc. (Amendment)

    SC 13D/A - DAVITA INC. (0000927066) (Subject)

    8/4/21 4:02:59 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $DVA
    Leadership Updates

    Live Leadership Updates

    View All

    DaVita Appoints Jessica Hergenreter as Chief People Officer

    DENVER, Oct. 17, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced Jessica (Jess) Hergenreter as its new chief people officer (CPO). In this position, Hergenreter will oversee DaVita's People Services team, leading initiatives to engage and uplift DaVita's more than 70,000 teammates (employees) worldwide. Earlier this year, DaVita was named as a Top Workplace by USA Today and one of America's Most Loved Companies by Newsweek. "Our incredible teammates are the difference makers for the care we provide to patients," said Javier Rodriguez, C

    10/17/24 1:00:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

    DENVER, Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer. This appointment builds on Maughan's 18-year tenure at DaVita in a range of leadership roles. After a celebrated 11-year tenure as chief operating officer, Mike Staffieri will step into the role of chief operating officer emeritus. Both appointments are effective September 15, 2024. "It's an exciting time for DaVita! Dave's extensive experience in operations leadership coupled with his deep knowledge of DaVita's business positions him well to build upon our incredible foundation of operational excellence and lead our on

    9/13/24 8:00:00 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    DaVita Appoints New Chief Information Officer

    Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita  DENVER, May 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that Madhu Narasimhan will assume the role of chief information officer (CIO), effective June 3, 2024. In this leadership position, Narasimhan will be responsible for accelerating the implementation of DaVita's industry-leading health technology platforms. She will oversee DaVita's technology innovation strategy, including enterprise priorities like Center Without Walls™ (CWOW®),

    5/13/24 9:00:00 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care